Comparison between Advanced Enzyme Technologies IPO and Dilip Buildcon IPO.
Advanced Enzyme Technologies IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Dilip Buildcon IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Advanced Enzyme Technologies IPO is up to ₹411.49 Cr whereas the issue size of the Dilip Buildcon IPO is up to ₹653.98 Cr. The final issue price of Advanced Enzyme Technologies IPO is ₹896.00 per share and of Dilip Buildcon IPO is ₹219.00 per share.
| Advanced Enzyme Technologies IPO | Dilip Buildcon IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹880.00 per share | ₹214.00 per share |
| Issue Price (Upper) | ₹896.00 per share | ₹219.00 per share |
| Issue Price (Final) | ₹896.00 per share | ₹219.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹86.00 per share | |
| Market Lot Size | 16 shares | 65 shares |
| Fresh Issue Size | 5,60,405 shares | 1,96,34,703 shares |
| Fresh Issue Size (Amount) | up to ₹50.19 Cr | up to ₹430.00 Cr |
| OFS Issue Size | 40,34,470 shares | 1,02,27,273 shares |
| OFS Issue Size (Amount) | up to ₹361.30 Cr | up to ₹223.98 Cr |
| Issue Size Total | 45,94,875 shares | 2,98,61,976 shares |
| Issue Size Total (Amount) | up to ₹411.49 Cr | up to ₹653.98 Cr |
Advanced Enzyme Technologies IPO opens on Jul 20, 2016, while Dilip Buildcon IPO opens on Aug 01, 2016. The closing date of Advanced Enzyme Technologies IPO and Dilip Buildcon IPO is Jul 22, 2016, and Aug 03, 2016, respectively.
| Advanced Enzyme Technologies IPO | Dilip Buildcon IPO | |
|---|---|---|
| Anchor Bid Date | Jul 19, 2016 | Jul 29, 2016 |
| Issue Open | Jul 20, 2016 | Aug 01, 2016 |
| Issue Close | Jul 22, 2016 | Aug 03, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Aug 01, 2016 | Aug 11, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Advanced Enzyme Technologies IPO P/E ratio is , as compared to Dilip Buildcon IPO P/E ratio of .
| Advanced Enzyme Technologies IPO | Dilip Buildcon IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.11 | |||||
| Promoter Shareholding (Post-Issue) | 49.52 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2000.41 Cr. | ₹2995.26 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 28.14% |
In the Advanced Enzyme Technologies IPO Retail Individual Investors (RII) are offered 15,99,565 shares while in Dilip Buildcon IPO retail investors are offered 15,99,565 shares. Qualified Institutional Buyers (QIB) are offered 9,14,038 shares in Advanced Enzyme Technologies IPO and 59,72,395 shares in Dilip Buildcon IPO.
| Advanced Enzyme Technologies IPO | Dilip Buildcon IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,71,053 shares | 89,58,592 shares |
| Market Maker Reservation | ||
| QIB | 9,14,038 shares | 59,72,395 shares |
| NII | 6,85,528 shares | 44,79,297 shares |
| RII | 15,99,565 shares | 1,04,51,692 shares |
| Employee | 24,691 shares | |
| Others | ||
| Total | 45,94,875 shares | 2,98,61,976 shares |
Advanced Enzyme Technologies IPO subscribed 116.02x in total, whereas Dilip Buildcon IPO subscribed 20.96x.
| Advanced Enzyme Technologies IPO | Dilip Buildcon IPO | |
|---|---|---|
| QIB (times) | 94.03x | 9.76x |
| NII (times) | 393.10x | 79.64x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.67x | 2.35x |
| Employee (times) | 1.73x | |
| Other (times) | ||
| Total (times) | 116.02x | 20.96x |
